Cannabinoids

We have an ambition to address unmet needs with best-in-class cannabinoid products and safe and effective delivery systems. We are doing this through Verdeya, a subsidiary of Aspeya.

Verdeya is pioneering a scientific and responsible approach to cannabinoids. With a patient mindset, it is developing and commercializing best-in-class medical and non-recreational cannabinoid products. Verdeya is doing this by combining scientific strength, world-class technical expertise, and data-driven insights.

Verdeya is committed to working with others to create consistent, high standards for cannabinoid quality, safety, and predictability.

To find out more, visit verdeyalife.com

Healthcare professional holding patient's hand
We believe that cannabinoids have a role to play in addressing health and wellbeing needs. There is a need for science-backed products and standards for safety and quality.
Julia Hoeng
JULIA HOENG
Vice President, Innovation & Product Development (Cannabinoids)